These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12750261)

  • 1. Loss of coordinated androgen regulation in nonmalignant ovarian epithelial cells with BRCA1/2 mutations and ovarian cancer cells.
    Evangelou A; Letarte M; Jurisica I; Sultan M; Murphy KJ; Rosen B; Brown TJ
    Cancer Res; 2003 May; 63(10):2416-24. PubMed ID: 12750261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
    Evangelou A; Jindal SK; Brown TJ; Letarte M
    Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of androgen receptor-associated protein 70 (ARA70) mRNA expression in ovarian cancer.
    Shaw PA; Rittenberg PV; Brown TJ
    Gynecol Oncol; 2001 Feb; 80(2):132-8. PubMed ID: 11161850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells.
    Syed V; Ulinski G; Mok SC; Yiu GK; Ho SM
    Cancer Res; 2001 Sep; 61(18):6768-76. PubMed ID: 11559549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
    Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
    Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
    Kim IY; Zelner DJ; Lee C
    Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line.
    Hofbauer LC; Hicok KC; Khosla S
    J Cell Biochem; 1998 Oct; 71(1):96-108. PubMed ID: 9736458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB; Moody TW; Mariano JM
    Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
    Lucia MS; Sporn MB; Roberts AB; Stewart LV; Danielpour D
    J Cell Physiol; 1998 May; 175(2):184-92. PubMed ID: 9525477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
    Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta.
    Havrilesky LJ; Hurteau JA; Whitaker RS; Elbendary A; Wu S; Rodriguez GC; Bast RC; Berchuck A
    Cancer Res; 1995 Feb; 55(4):944-8. PubMed ID: 7531618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
    Ripley D; Tang XM; Ma C; Chegini N
    Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
    Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
    Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors.
    Yamada SD; Baldwin RL; Karlan BY
    Gynecol Oncol; 1999 Oct; 75(1):72-7. PubMed ID: 10502429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.
    Hussein-Fikret S; Fuller PJ
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):149-60. PubMed ID: 15607539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
    Dabrow MB; Francesco MR; McBrearty FX; Caradonna S
    Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
    Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines.
    Zeinoun Z; Teugels E; De Bleser PJ; Neyns B; Geerts A; De Greve J
    Anticancer Res; 1999; 19(1A):413-20. PubMed ID: 10226576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance.
    McCaffrey TA; Du B; Fu C; Bray PJ; Sanborn TA; Deutsch E; Tarazona N; Shaknovitch A; Newman G; Patterson C; Bush HL
    J Mol Cell Cardiol; 1999 Sep; 31(9):1627-42. PubMed ID: 10471347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.